What T. Rowe Price Associates Inc changed, 2013 to 2026
53 quarterly 13F filings, from Q2 2013 to Q2 2026, each read from the filing itself. A quarter is compared only with the quarter before it, so a quarter with no filing is a gap in the record, not a sale.
Reported book
$999bn
$374bn at Q2 2013
Positions
3,241
2,429 at Q2 2013
Top ten weight
32%
12% at Q2 2013
Typical quarterly turnover
about 7%
Estimated from share changes
- Q2 2013: $374bn
- Q3 2013: $400bn
- Q4 2013: $436bn
- Q1 2014: $445bn
- Q2 2014: $463bn
- Q3 2014: $458bn
- Q4 2014: $471bn
- Q1 2015: $484bn
- Q2 2015: $486bn
- Q3 2015: $449bn
- Q4 2015: $475bn
- Q1 2016: $468bn
- Q2 2016: $472bn
- Q3 2016: $498bn
- Q4 2016: $504bn
- Q1 2017: $534bn
- Q2 2017: $556bn
- Q3 2017: $585bn
- Q4 2017: $616bn
- Q1 2018: $629bn
- Q2 2018: $654bn
- Q3 2018: $685bn
- Q4 2018: $591bn
- Q1 2019: $680bn
- Q2 2019: $712bn
- Q3 2019: $706bn
- Q4 2019: $771bn
- Q1 2020: $632bn
- Q2 2020: $795bn
- Q3 2020: $864bn
- Q4 2020: $974bn
- Q1 2021: $999bn
- Q2 2021: $1079bn
- Q3 2021: $1062bn
- Q4 2021: $1111bn
- Q1 2022: $992bn
- Q2 2022: $791bn
- Q3 2022: $610bn
- Q4 2022: $622bn
- Q1 2023: $668bn
- Q2 2023: $718bn
- Q3 2023: $682bn
- Q4 2023: $744bn
- Q1 2024: $816bn
- Q2 2024: $836bn
- Q3 2024: $869bn
- Q4 2024: $867bn
- Q1 2025: $812bn
- Q2 2025: $883bn
- Q3 2025: $935bn
- Q4 2025: $927bn
- Q1 2026: $865bn
- Q2 2026: $999bn
- Q2 2013: 12%
- Q3 2013: 12%
- Q4 2013: 13%
- Q1 2014: 12%
- Q2 2014: 12%
- Q3 2014: 12%
- Q4 2014: 12%
- Q1 2015: 12%
- Q2 2015: 13%
- Q3 2015: 15%
- Q4 2015: 16%
- Q1 2016: 16%
- Q2 2016: 16%
- Q3 2016: 17%
- Q4 2016: 16%
- Q1 2017: 18%
- Q2 2017: 18%
- Q3 2017: 18%
- Q4 2017: 19%
- Q1 2018: 19%
- Q2 2018: 21%
- Q3 2018: 20%
- Q4 2018: 20%
- Q1 2019: 21%
- Q2 2019: 21%
- Q3 2019: 21%
- Q4 2019: 22%
- Q1 2020: 24%
- Q2 2020: 25%
- Q3 2020: 26%
- Q4 2020: 24%
- Q1 2021: 24%
- Q2 2021: 26%
- Q3 2021: 26%
- Q4 2021: 28%
- Q1 2022: 28%
- Q2 2022: 26%
- Q3 2022: 31%
- Q4 2022: 27%
- Q1 2023: 28%
- Q2 2023: 32%
- Q3 2023: 31%
- Q4 2023: 31%
- Q1 2024: 32%
- Q2 2024: 36%
- Q3 2024: 34%
- Q4 2024: 35%
- Q1 2025: 32%
- Q2 2025: 36%
- Q3 2025: 37%
- Q4 2025: 37%
- Q1 2026: 34%
- Q2 2026: 32%
The positions that defined it
Every position that was ever among the 25 largest: when it first appeared, when it was largest, and where it stands in Q2 2026. The line is its reported value each quarter.
| Position | Value over time | First listed | Largest | Q2 2026 |
|---|---|---|---|---|
| Nvidia Corp(NVDA) | Q4 2016 | $74.0bnQ2 2026 | $74.0bn | |
| Apple Inc(AAPL) | Q2 2013 | $55.3bnQ4 2025 | $46.2bn | |
| Alphabet Inc(GOOGL) | Q4 2015 | $36.2bnQ2 2026 | $36.2bn | |
| Microsoft Corp(MSFT) | Q2 2013 | $68.7bnQ4 2021 | $32.6bn | |
| Broadcom Inc(AVGO) | Q2 2018 | $31.3bnQ2 2026 | $31.3bn | |
| Amazon Com(AMZN) | Q2 2013 | $55.6bnQ2 2021 | $26.0bn | |
| Alphabet Inc(GOOG) | Q4 2015 | $38.6bnQ4 2021 | $20.9bn | |
| Advanced Micro Devices(AMD) | Q3 2019 | $20.9bnQ2 2026 | $20.9bn | |
| Facebook Inc(META) | Q2 2013 | $35.3bnQ2 2021 | $17.3bn | |
| Lilly (eli) and Company(LLY) | Q2 2013 | $18.7bnQ2 2024 | $16.7bn | |
| Micron Technology(MU) | Q2 2013 | $16.4bnQ2 2026 | $16.4bn | |
| Visa Inc(V) | Q2 2013 | $19.3bnQ2 2021 | $12.2bn | |
| Rivian Automotive Inc(RIVN) | Q4 2021 | $16.1bnQ4 2021 | Below the listed rangelast listed Q2 2024 | |
| General Electric Company | Q2 2013 | $10.9bnQ2 2021 | Soldlast listed Q2 2021 | |
| Global Payments Inc(GPN) | Q2 2013 | $10.5bnQ4 2020 | Below the listed rangelast listed Q1 2025 | |
| Google Inc | Q2 2013 | $10.5bnQ4 2013 | Soldlast listed Q3 2015 | |
| Snap Inc(SNAP) | Q1 2017 | $10.3bnQ3 2021 | Below the listed rangelast listed Q4 2023 | |
| Priceline Com Inc | Q2 2013 | $10.0bnQ1 2017 | Soldlast listed Q4 2017 | |
| PayPal HLDGS Inc(PYPL) | Q4 2015 | $9.3bnQ4 2020 | Below the listed rangelast listed Q4 2024 | |
| Fiserv Inc(FISV) | Q2 2013 | $7.1bnQ1 2024 | Below the listed rangelast listed Q1 2026 |
Quarter by quarter
Q1 2025: $812bn across 3,040 positions
Against Q4 2024: 104 new, 2,010 added to, 741 trimmed, 71 sold out, across all 3,040 positions.
Turnover about 6% of the book, estimated from share changes at quarter-end prices.
Largest additions
- Gilead Sciences Inc (GILD)+$1.3bn
- Berkshire Hathaway Inc. (BRK-B)+$1.2bn
- General Electric Co (GE)+$1.1bn
- Valero Energy Corp (VLO)+$1.1bn
- Mondelez International Inc (MDLZ)+$1.1bn
- Charles Schwab Corp (SCHW)+$1.0bn
- Intercontinentalexchange (ICE)+$948m
- Cigna Corp New (CI)+$940m
Largest reductions
- Nvidia Corp (NVDA)-$14.6bn
- Microsoft Corp (MSFT)-$7.6bn
- Apple Inc (AAPL)-$7.4bn
- Amazon Com (AMZN)-$6.7bn
- Tesla Motors Inc (TSLA)-$5.5bn
- Alphabet Inc (GOOGL)-$4.9bn
- Alphabet Inc (GOOG)-$3.1bn
- Servicenow Inc (NOW)-$2.3bn
Opened
Nothing new among the largest positions.
Sold out
- Summit Matls Incwas $271m
- Barrick Gold Corp.was $105m
- Endeavor Group HLDGS Incwas $57m
- Kinross Gold Corp (KGC)was $44m
- Biontech Se (BNTX)was $36m
- Bilibili Inc (BILI)was $18m
- Hudbay Minerals Inc (HBM)was $18m
- Immatics N.v (IMTX)was $18m
Largest positions, Q1 2025
The largest 25 of 3,040 reported positions; the largest 500 carry 96.1% of the reported value.
| Position | Value | Weight | On the quarter |
|---|---|---|---|
| Microsoft Corp (MSFT) | $49.4bn | 6.1% | Trimmed |
| Apple Inc (AAPL) | $47.7bn | 5.9% | Trimmed |
| Nvidia Corp (NVDA) | $40.6bn | 5.0% | Trimmed |
| Amazon Com (AMZN) | $33.4bn | 4.1% | Trimmed |
| Facebook Inc (META) | $22.6bn | 2.8% | Trimmed |
| Lilly (eli) and Company (LLY) | $15.8bn | 1.9% | Trimmed |
| Visa Inc (V) | $15.0bn | 1.8% | Trimmed |
| Alphabet Inc (GOOGL) | $13.8bn | 1.7% | Trimmed |
| Alphabet Inc (GOOG) | $12.1bn | 1.5% | Trimmed |
| Unitedhealth Group Inc (UNH) | $11.2bn | 1.4% | Trimmed |
| Mastercard Inc (MA) | $11.0bn | 1.4% | Added |
| Broadcom Inc (AVGO) | $11.0bn | 1.4% | Added |
| Netflix Inc (NFLX) | $10.9bn | 1.3% | Added |
| JP Morgan Chase & Co (JPM) | $7.1bn | 0.9% | Trimmed |
| Fiserv Inc (FISV) | $6.9bn | 0.9% | Trimmed |
| Intuitive Surgical Inc. (ISRG) | $6.8bn | 0.8% | Trimmed |
| Charles Schwab Corp (SCHW) | $6.4bn | 0.8% | Added |
| Servicenow Inc (NOW) | $6.1bn | 0.8% | Trimmed |
| Tesla Motors Inc (TSLA) | $6.0bn | 0.7% | Trimmed |
| Berkshire Hathaway Inc. (BRK-B) | $5.9bn | 0.7% | Added |
| Intuit (INTU) | $5.5bn | 0.7% | Added |
| Exxon Mobil Corporation (XOM) | $5.3bn | 0.6% | Trimmed |
| Kenvue Inc (KVUE) | $5.1bn | 0.6% | Trimmed |
| General Electric Co (GE) | $5.0bn | 0.6% | Added |
| Thermo Fisher Scientific Inc. (TMO) | $4.6bn | 0.6% | Trimmed |
The books most like this one
Among the managers whose filings are on file, at Q2 2026. Overlap is the share of the two books that is the same: for every stock both list, the smaller of its two weights, added up. Two books can overlap because both own the largest companies; it says nothing about whether the managers agree.
| Manager | Overlap | Stocks in both | Overlap over time | |
|---|---|---|---|---|
| Fidelity (FMR LLC) | at least 59% | 278 | Compare | |
| Invesco Ltd | at least 58% | 301 | Compare | |
| Wellington Management Group LLP | at least 54% | 282 | Compare | |
| AllianceBernstein LP | at least 52% | 261 | Compare | |
| Capital Research Global Investors | at least 51% | 218 | Compare | |
| Neuberger Berman Group LLC | at least 51% | 246 | Compare | |
| Janus Henderson Group Ltd | at least 50% | 228 | Compare | |
| Capital World Investors | at least 48% | 236 | Compare |
“At least” where either manager has more positions than are read each quarter: a stock both hold below that range is not counted.
The filings behind it
Every quarter above is one 13F holdings report, with any amendment the filer made to it applied in the order it was filed. Where the reporting entity changed, each quarter keeps the filer that actually reported it.
| Quarter | Filer | Book | Amended | Filing |
|---|---|---|---|---|
| Q2 2026 | T. Rowe Price Associates Inc | $999bn | 13F-HR | |
| Q1 2026 | T. Rowe Price Associates Inc | $865bn | 13F-HR | |
| Q4 2025 | T. Rowe Price Associates Inc | $927bn | 13F-HR | |
| Q3 2025 | T. Rowe Price Associates Inc | $935bn | 13F-HR | |
| Q2 2025 | T. Rowe Price Associates Inc | $883bn | 13F-HR | |
| Q1 2025 | T. Rowe Price Associates Inc | $812bn | 13F-HR | |
| Q4 2024 | T. Rowe Price Associates Inc | $867bn | 13F-HR | |
| Q3 2024 | T. Rowe Price Associates Inc | $869bn | 13F-HR | |
| Q2 2024 | T. Rowe Price Associates Inc | $836bn | 13F-HR | |
| Q1 2024 | T. Rowe Price Associates Inc | $816bn | 13F-HR | |
| Q4 2023 | T. Rowe Price Associates Inc | $744bn | 13F-HR | |
| Q3 2023 | T. Rowe Price Associates Inc | $682bn | 13F-HR | |
| Q2 2023 | T. Rowe Price Associates Inc | $718bn | 13F-HR | |
| Q1 2023 | T. Rowe Price Associates Inc | $668bn | 13F-HR | |
| Q4 2022 | T. Rowe Price Associates Inc | $622bn | 13F-HR | |
| Q3 2022 | T. Rowe Price Associates Inc | $610bn | 13F-HR | |
| Q2 2022 | T. Rowe Price Associates Inc | $791bn | 13F-HR | |
| Q1 2022 | T. Rowe Price Associates Inc | $992bn | 13F-HR | |
| Q4 2021 | T. Rowe Price Associates Inc | $1111bn | 13F-HR | |
| Q3 2021 | T. Rowe Price Associates Inc | $1062bn | 13F-HR | |
| Q2 2021 | T. Rowe Price Associates Inc | $1079bn | 13F-HR | |
| Q1 2021 | T. Rowe Price Associates Inc | $999bn | 13F-HR | |
| Q4 2020 | T. Rowe Price Associates Inc | $974bn | 13F-HR | |
| Q3 2020 | T. Rowe Price Associates Inc | $864bn | 13F-HR | |
| Q2 2020 | T. Rowe Price Associates Inc | $795bn | 13F-HR | |
| Q1 2020 | T. Rowe Price Associates Inc | $632bn | 13F-HR | |
| Q4 2019 | T. Rowe Price Associates Inc | $771bn | 13F-HR | |
| Q3 2019 | T. Rowe Price Associates Inc | $706bn | 13F-HR | |
| Q2 2019 | T. Rowe Price Associates Inc | $712bn | 13F-HR | |
| Q1 2019 | T. Rowe Price Associates Inc | $680bn | 13F-HR | |
| Q4 2018 | T. Rowe Price Associates Inc | $591bn | 13F-HR | |
| Q3 2018 | T. Rowe Price Associates Inc | $685bn | 13F-HR | |
| Q2 2018 | T. Rowe Price Associates Inc | $654bn | 13F-HR | |
| Q1 2018 | T. Rowe Price Associates Inc | $629bn | 13F-HR | |
| Q4 2017 | T. Rowe Price Associates Inc | $616bn | 13F-HR | |
| Q3 2017 | T. Rowe Price Associates Inc | $585bn | 13F-HR | |
| Q2 2017 | T. Rowe Price Associates Inc | $556bn | 13F-HR | |
| Q1 2017 | T. Rowe Price Associates Inc | $534bn | 13F-HR | |
| Q4 2016 | T. Rowe Price Associates Inc | $504bn | 13F-HR | |
| Q3 2016 | T. Rowe Price Associates Inc | $498bn | 13F-HR | |
| Q2 2016 | T. Rowe Price Associates Inc | $472bn | 13F-HR | |
| Q1 2016 | T. Rowe Price Associates Inc | $468bn | 13F-HR | |
| Q4 2015 | T. Rowe Price Associates Inc | $475bn | 13F-HR | |
| Q3 2015 | T. Rowe Price Associates Inc | $449bn | 13F-HR | |
| Q2 2015 | T. Rowe Price Associates Inc | $486bn | 13F-HR | |
| Q1 2015 | T. Rowe Price Associates Inc | $484bn | 13F-HR | |
| Q4 2014 | T. Rowe Price Associates Inc | $471bn | 13F-HR | |
| Q3 2014 | T. Rowe Price Associates Inc | $458bn | 13F-HR | |
| Q2 2014 | T. Rowe Price Associates Inc | $463bn | 13F-HR | |
| Q1 2014 | T. Rowe Price Associates Inc | $445bn | 13F-HR | |
| Q4 2013 | T. Rowe Price Associates Inc | $436bn | 1 | 13F-HR |
| Q3 2013 | T. Rowe Price Associates Inc | $400bn | 13F-HR | |
| Q2 2013 | T. Rowe Price Associates Inc | $374bn | 1 | 13F-HR |
Reading this record
A 13F lists US-listed long equity and options at the quarter end, filed up to 45 days later. It shows what was held, not when it was bought or at what price, and nothing short. Where a quarter lists only the largest positions, a name missing from it may still be held below that range; the counts of what was opened and sold always cover the whole filing.
Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More